PSA testing: are patients aware of what lies ahead?

Author： Lamplugh Marc Gilmore Paul Quinlan Timothy Cornford Philip

Publisher： The Royal College of Surgeons of England

ISSN： 1478-7083

Source： Annals of The Royal College of Surgeons of England, Vol.88, Iss.3, 2006-05, pp. : 284-288

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Did the rate of incidental prostate cancer change in the era of PSA testing? A retrospective study of 1127 patients

By Zigeuner R.E. Lipsky K. Riedler I. Auprich M. Schips L. Salfellner M. Pummer K. Hubmer G.

Urology, Vol. 62, Iss. 3, 2003-09 ,pp. : 451-455

Elsevier

Access to resources Recommend Favorite

What does postradiotherapy PSA nadir tell us about freedom from PSA failure and progression-free survival in patients with low and intermediate-risk localized prostate cancer?

By DeWitt K.D. Sandler H.M. Weinberg V. McLaughlin P.W. Roach M.

Urology, Vol. 62, Iss. 3, 2003-09 ,pp. : 492-496

Elsevier

Access to resources Recommend Favorite

Does PSA Testing Influence the Natural History of Prostate Cancer?

By Anderson J.

European Urology Supplements, Vol. 1, Iss. 5, 2002-08 ,pp. : 3-10

Elsevier

Access to resources Recommend Favorite

Serum prostate-specific antigen levels (PSA) in men without clinical evidence of prostate cancer: age-specific reference ranges for total PSA, free PSA, and percent free PSA - what's new in 1997

By Kalish L.A. McKinlay J.B.

Urology, Vol. 54, Iss. 6, 1999-12 ,pp. : 1022-1027

Elsevier

Access to resources Recommend Favorite

Impact of chronic dialysis on serum PSA, free PSA, and free/total PSA ratio: is prostate cancer detection compromised in patients receiving long-term dialysis?

By Djavan B. Shariat S. Ghawidel K. G uven-Marberger K. Remzi M. Kovarik J. Hoerl W.H. Marberger M.

Urology, Vol. 53, Iss. 6, 1999-06 ,pp. : 1169-1174

Elsevier

Access to resources Recommend Favorite